Carazolol
From Self-sufficiency
Revision as of 14:08, 30 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s): cardiovascular-drug-stub)
150px | |
Systematic (IUPAC) name | |
---|---|
1-(9H-carbazol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol | |
Identifiers | |
CAS Number | 57775-29-8 |
ATCvet code | QC07AA90 (WHO) |
PubChem | CID 71739 |
IUPHAR/BPS | 569 |
ChemSpider | 64783 |
Chemical data | |
Formula | C18H22N2O2 |
Molar mass | 298.38[[Script error: No such module "String".]] |
Script error: No such module "collapsible list". |
Carazolol is a high affinity antagonist/partial inverse agonist (also referred to as a beta blocker) of the β-adrenergic receptor.[1]
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
External links
30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
- ↑ Innis RB, Corrēa FM, Synder SH (1979). "Carazolol, an extremely potent beta-adrenergic blocker: binding to beta-receptors in brain membranes". Life Sci. 24 (24): 2255–64. doi:10.1016/0024-3205(79)90102-4. PMID 41147.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Carbazoles
- Phenol ethers
- Alcohols
- Cardiovascular system drug stubs
- 2Fix
- CS1 maint: Multiple names: authors list